Home Insiders Updates A Guide To The Risks Of Investing In Ocuphire Pharma Inc. (OCUP)

A Guide To The Risks Of Investing In Ocuphire Pharma Inc. (OCUP)

A Guide To The Risks Of Investing In Ocuphire Pharma Inc. (OCUP)

Ocuphire Pharma Inc.’s filing revealed that its President and CEO Sooch Mina acquired Company’s shares for reported $25300.0 on May 20. In the deal valued at $2.02 per share,12,500 shares were bought. As a result of this transaction, Sooch Mina now holds 425,022 shares worth roughly $ 0.88 million.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Then, MANUSO JAMES S J bought 5,000 shares, generating $9,950 in total proceeds. Upon buying the shares at $1.99, the Director now owns 21,570 shares.

Before that, Sooch Mina bought 12,500 shares. Ocuphire Pharma Inc. shares valued at $25,879 were divested by the President and CEO at a price of $2.07 per share. As a result of the transaction, Sooch Mina now holds 412,522 shares, worth roughly $0.86 million.

Price Performance Review of OCUP

On Monday, Ocuphire Pharma Inc. [NASDAQ:OCUP] saw its stock fall -5.02% to $2.08. On the same session, the stock had its day’s lowest price of $2.08, but rose to a high of $2.1899. Over the last five days, the stock has lost -11.49%. Ocuphire Pharma Inc. shares have fallen nearly -44.24% since the year began. Nevertheless, the stocks have fallen -51.29% over the past one year. While a 52-week high of $5.50 was reached on 03/25/22, a 52-week low of $1.78 was recorded on 06/16/22. SMA at 50 days reached $2.23, while 200 days put it at $2.50. A total of 0.68 million shares were traded, compared to the trading of 91200.0 shares in the previous session.

Levels Of Support And Resistance For OCUP Stock

The 24-hour chart illustrates a support level at 2.04, which if violated will result in even more drops to 2.01. On the upside, there is a resistance level at 2.15. A further resistance level may holdings at 2.23. The Relative Strength Index (RSI) on the 14-day chart is 39.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.88%. Stochastics %K at 17.69% indicates the stock is a buying.

How much short interest is there in Ocuphire Pharma Inc.?

A steep rise in short interest was recorded in Ocuphire Pharma Inc. stocks on Jul 14, 2022, dropping by 47590.0 shares to a total of 0.26 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 0.31 million shares. There was a decline of -18.36%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 1.39% of the overall stock float, the days-to-cover ratio (short ratio) fell to 3.09.

Ocuphire Pharma Inc. [OCUP] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 697,295 shares, or roughly 3.39% of the outstanding OCUP shares. Additionally, Rice, Hall, James & Associates LL increased 64.99% of its stake after which the total value it holdings stand at $1,086,099, while Richmond Brothers, Inc. added 2.96% of its stake to hold $0.64 million in the firm. At present, Geode Capital Management LLC is holding 147,459 shares valued at $0.3 million. BlackRock Fund Advisors owned 68,836 shares of the company at the time of its most recent 13F filing, worth $0.14 million.

According to FactSet, Ocuphire Pharma Inc.’s share price will average $25.40 in the next year, based on opinions of analysts polled by the firm. This is up nearly 1041.55 percent from its previous closing price of $2.19. Analysts expect Ocuphire Pharma Inc. stock to reach the higher price of $29.00, while the lowest price estimate is $23.00. However, 6 analysts have rated OCUP stock as a Buy in their predictions for 2022.


Please enter your comment!
Please enter your name here